BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1371611)

  • 1. The substance P fragment SP(1-7) stimulates motor behavior and nigral dopamine release.
    Hall ME; Stewart JM
    Pharmacol Biochem Behav; 1992 Jan; 41(1):75-8. PubMed ID: 1371611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of substance P and SP(1-7) on dopamine release from rat substantia nigra.
    Hall ME; Nockels C; Stewart JM
    Ann N Y Acad Sci; 1991; 632():407-9. PubMed ID: 1719889
    [No Abstract]   [Full Text] [Related]  

  • 3. Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments.
    Reid MS; Herrera-Marschitz M; Terenius L; Ungerstedt U
    Brain Res; 1990 Sep; 526(2):228-34. PubMed ID: 1701682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of substance P and neurokinin A (substance K) on motor behavior: unique effect of substance P attributable to its amino-terminal sequence.
    Hall ME; Grantham P; Limoli J; Stewart JM
    Brain Res; 1987 Sep; 420(1):82-94. PubMed ID: 2445433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranigral or intrastriatal injections of GDNF: effects on monoamine levels and behavior in rats.
    Martin D; Miller G; Cullen T; Fischer N; Dix D; Russell D
    Eur J Pharmacol; 1996 Dec; 317(2-3):247-56. PubMed ID: 8997607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural response to bilateral injections of substance P into the substantia nigra of the rat.
    Kelley AE; Iversen SD
    Brain Res; 1978 Dec; 158(2):474-8. PubMed ID: 709379
    [No Abstract]   [Full Text] [Related]  

  • 7. Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolism.
    Humpel C; Saria A; Regoli D
    Eur J Pharmacol; 1991 Mar; 195(1):107-14. PubMed ID: 1712305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists.
    Elliott PJ; Mason GS; Stephens-Smith M; Hagan RM
    Neuropeptides; 1991 Jun; 19(2):119-26. PubMed ID: 1719444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of tachykinins injected intranigrally on striatal dopamine metabolism.
    Tan DP; Tsou K
    J Neurochem; 1988 Nov; 51(5):1333-7. PubMed ID: 2459306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptor subsensitivity in the substantia nigra after chronic morphine treatment in rats.
    Spampinato U; Gozlan H; Daval G; Fattaccini CM; Hamon M
    Eur J Pharmacol; 1988 May; 150(1-2):113-22. PubMed ID: 2456939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance P infusion into substantia nigra of the rat: behavioural analysis and involvement of striatal dopamine.
    Kelley AE; Iversen SD
    Eur J Pharmacol; 1979 Dec; 60(2-3):171-9. PubMed ID: 93550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The substance P(1-7) fragment is a potent modulator of substance P actions in the brain.
    Herrera-Marschitz M; Terenius L; Sakurada T; Reid MS; Ungerstedt U
    Brain Res; 1990 Jun; 521(1-2):316-20. PubMed ID: 1698511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis.
    Santiago M; Rollema H; de Vries JB; Westerink BH
    Brain Res; 1991 Jan; 538(2):226-30. PubMed ID: 1707325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of GABA, dopamine, and substance P on the release of newly synthesized 3H-5-hydroxytryptamine from rat substantia nigra in vitro.
    Reubi JC; Emson PC; Jessell TM; Iversen LL
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 304(3):271-5. PubMed ID: 714184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intranigral substance P and neurokinin A injections on extracellular dopamine levels measured with microdialysis in the striatum and frontoparietal cortex of rats.
    Reid MS; Herrera-Marschitz M; Ungerstedt U
    J Neurochem; 1991 Sep; 57(3):970-4. PubMed ID: 1713616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
    Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats.
    Santiago M; Westerink BH
    J Neurochem; 1991 Sep; 57(3):738-47. PubMed ID: 1677674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The behavioural effects of a novel substance P analogue following infusion into the ventral tegmental area or substantia nigra of rat brain.
    Eison AS; Eison MS; Iversen SD
    Brain Res; 1982 Apr; 238(1):137-52. PubMed ID: 6177380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of calcitonin on rat extrapyramidal motor system: behavioral and biochemical data.
    Nicoletti F; Clementi G; Patti F; Canonico PL; Di Giorgio RM; Matera M; Pennisi G; Angelucci L; Scapagnini U
    Brain Res; 1982 Nov; 250(2):381-5. PubMed ID: 6293644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral analysis of the effect of substance P injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat.
    Kelley AE; Cador M; Stinus L
    Psychopharmacology (Berl); 1985; 85(1):37-46. PubMed ID: 2580328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.